Skip to main content

Race for Cure Drives Biotech Stocks

From VanEck Global With the COVID-19 pandemic showing few signs of easing, biotech companies are racing to meet soaring demand for treatments, vaccines and testing kits. This is helping to drive renewed investor interest in the biotech sector. Recent developments by some biotech firms have not only...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.